Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 3 Kidney Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Prostatic Neoplasms 1 Pain, Postoperative 1 Pain 1 Neoplasms 1 Intraoperative Complications 1 Inflammatory Bowel Diseases 1 Fibroadenoma 1 Diverticulitis 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bone Neoplasms 1 Arrhythmias, Cardiac 1 Anesthesia 1

Interventions

Sunitinib 145 Nivolumab 144 pembrolizumab 132 Sorafenib 84 Bevacizumab 77 Everolimus 74 cabozantinib 71 pazopanib 65 Axitinib 65 Ipilimumab 62 aldesleukin 52 Magnetic Resonance Spectroscopy 45 Cyclophosphamide 40 Interleukin-2 38 lenvatinib 37 Specimen Handling 36 Radiosurgery 36 Interferon-alpha 32 atezolizumab 30 temsirolimus 27 belzutifan 24 Gemcitabine 23 fludarabine phosphate 22 avelumab 22 Radiotherapy 19 Interferon alpha-2 19 Biopsy 18 fludarabine 17 durvalumab 17 Nephrectomy 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Anesthesia, Epidural × Clear all

NCT02030717 2015-06-04

ASA

Umeå University

Phase 2/3 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡